TW200738254A - Method and composition for protection against radiation - Google Patents

Method and composition for protection against radiation

Info

Publication number
TW200738254A
TW200738254A TW096109327A TW96109327A TW200738254A TW 200738254 A TW200738254 A TW 200738254A TW 096109327 A TW096109327 A TW 096109327A TW 96109327 A TW96109327 A TW 96109327A TW 200738254 A TW200738254 A TW 200738254A
Authority
TW
Taiwan
Prior art keywords
protection
ionizing radiation
composition
protection against
against radiation
Prior art date
Application number
TW096109327A
Other languages
English (en)
Inventor
Ning-Man Cheng
Original Assignee
Bio Cancer Treatment Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Cancer Treatment Int Ltd filed Critical Bio Cancer Treatment Int Ltd
Publication of TW200738254A publication Critical patent/TW200738254A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW096109327A 2006-03-17 2007-03-19 Method and composition for protection against radiation TW200738254A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78304006P 2006-03-17 2006-03-17

Publications (1)

Publication Number Publication Date
TW200738254A true TW200738254A (en) 2007-10-16

Family

ID=38255488

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096109327A TW200738254A (en) 2006-03-17 2007-03-19 Method and composition for protection against radiation

Country Status (7)

Country Link
US (1) US20090068166A1 (zh)
EP (1) EP1996225A1 (zh)
CN (1) CN101478982A (zh)
AU (1) AU2007228435A1 (zh)
RU (1) RU2008137226A (zh)
TW (1) TW200738254A (zh)
WO (1) WO2007107929A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0906462A2 (pt) 2008-02-08 2015-07-14 Colgate Palmolive Co Método para tratar, melhorar, inibir ou evitar boca seca, saliva artificial, uso de um aminoácido básico em forma livre ou de sal, e, aminoácido básico em forma livre ou de sal
CN103184209B (zh) * 2011-12-27 2015-09-16 拜奥生物科技（上海）有限公司 人精氨酸酶和聚乙二醇化人精氨酸酶及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
WO2003063780A2 (en) * 2002-01-25 2003-08-07 Cancer Treatments International Therapeutic composition for treatment of cancer by arginine depletion
HK1053577A2 (en) * 2002-06-20 2003-10-10 Bio Cancer Treatment Int Ltd Pharmaceutical composition and method of treatment of human malignanices with arginine deprivation

Also Published As

Publication number Publication date
RU2008137226A (ru) 2010-04-27
WO2007107929A1 (en) 2007-09-27
EP1996225A1 (en) 2008-12-03
AU2007228435A1 (en) 2007-09-27
US20090068166A1 (en) 2009-03-12
CN101478982A (zh) 2009-07-08

Similar Documents

Publication Publication Date Title
CY1122984T1 (el) Καρβαμιδικες ενωσεις και μεθοδοι παρασκευης και χρησης τους
IL260127B (en) mek inhibitors and methods of using them
MX361467B (es) Compuestos de isoindolina para uso en el tratamiento de cancer.
EP3718560A3 (en) Cyclin dependent kinase inhibitors and methods of use
MX2014012381A (es) Terapia de combinacion para tratar cancer.
MX2009010066A (es) Composiciones y metodos para la ablacion especifica de la evasion mutacional de terapias especificas para cancer.
WO2011034627A3 (en) Methods and apparatus for introducing cells at a tissue site
ATE510538T1 (de) Zusammensetzungen und verfahren für nervenschutz
SG164368A1 (en) Treatment of cancer
NZ593343A (en) Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
HK1152883A1 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
MX2013010770A (es) Tratamiento de tumores solidos.
MY162903A (en) Methods of treatment of pancreatic cancer
MX351975B (es) Composiciones y metodos para el tratamiento de infecciones y tumores.
TN2009000292A1 (en) Formulations for cancer treatment
WO2009072004A3 (en) Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
EA201001196A1 (ru) Соединения 4-пиридинона и их применение для лечения рака
WO2013192423A3 (en) Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
WO2019164593A3 (en) Methods and compositions utilizing rrx-001 combination therapy for radioprotection
MX2010006090A (es) Biomarcadores para predecir la sensibilidad de las celulas ante compuestos inmunomoduladores durante el tratamiento de linfoma de no hodgkin.
WO2010051320A3 (en) Methods for assembling panels of cancer cell lines for use in testing the efficacy of one or more pharmaceutical compositions
MX2022004571A (es) Alquilésteres de alfa-metil-dl-tirosina para uso en el tratamiento de cáncer.
WO2008025830A3 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
WO2012019154A3 (en) Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy